help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NISHINO, T.
Right arrow Articles by SATO, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NISHINO, T.
Right arrow Articles by SATO, J.

Am. J. Respir. Crit. Care Med., Volume 161, Number 6, June 2000, 1963-1967

Inhaled Furosemide Greatly Alleviates the Sensation of Experimentally Induced Dyspnea

TAKASHI NISHINO, TOHRU IDE, TOMOKO SUDO, and JIRO SATO

Department of Anesthesiology, School of Medicine, Chiba University, Chiba, Japan

Furosemide is known to influence the activity of vagally mediated mechanoreceptors in the airways. Because vagal afferent fibers may play an important role in modulation of the sensation of dyspnea, it is possible that inhaled furosemide may modify the sensation of dyspnea. In a double-blind, randomized, crossover study, we compared the effect of inhaled furosemide on dyspneic sensation with that of placebo. Severe dyspneic sensation was induced in 12 healthy subjects in two ways: (1) breathholding and (2) loaded breathing with a combination of inspiratory resistive load (240 cm H2O/L/s) and hypercapnia induced by extra mechanical dead space (0.26 L). Subjects were asked to rate their sensation of respiratory discomfort using a visual analogue scale (dyspneic VAS). Breathholding times and changes in dyspneic VAS score during a 5-min period of loaded breathing were measured after inhalation of placebo and furosemide (40 mg). Total breathholding time after inhalation of furosemide (median, 93 [interquartile range, 78 to 112]s) was prolonged compared with the total breathholding time after placebo inhalation (67 [47-74]s). We also found that respiratory discomfort during loaded breathing after inhalation of furosemide develops more slowly and is less than that observed after inhalation of placebo. Our findings indicate that inhaled furosemide greatly alleviates the sensation of dyspnea induced experimentally by breathholding and by a combination of resistive loading and hypercapnia.




This article has been cited by other articles:


Home page
 ThoraxHome page
A Wilcock, A Walton, C Manderson, L Feathers, B E. Khoury, M Lewis, A Chauhan, P Howard, S Bell, J Frisby, et al.
Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer
Thorax, October 1, 2008; 63(10): 872 - 875.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D Jensen, K Amjadi, V Harris-McAllister, K A Webb, and D E O'Donnell
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD
Thorax, July 1, 2008; 63(7): 606 - 613.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
T. Nishino, S. Isono, N. Shinozuka, and T. Ishikawa
Coughing induced by airway irritation modulates the sensation of air hunger
J. Physiol., January 15, 2008; 586(2): 649 - 658.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Vovk and A. P. Binks
Raising end-expiratory volume relieves air hunger in mechanically ventilated healthy adults
J Appl Physiol, September 1, 2007; 103(3): 779 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. B. Mazzone and A. E. McGovern
Na+-K+-2Cl- cotransporters and Cl- channels regulate citric acid cough in guinea pigs
J Appl Physiol, August 1, 2006; 101(2): 635 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
B. J. Undem and M. Kollarik
The Role of Vagal Afferent Nerves in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 355 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Scano, L. Stendardi, and M. Grazzini
Understanding dyspnoea by its language
Eur. Respir. J., February 1, 2005; 25(2): 380 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K.-C. Ong, A.-C. Kor, W.-F. Chong, A. Earnest, and Y.-T. Wang
Effects of Inhaled Furosemide on Exertional Dyspnea in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 1028 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Sleep-disordered Breathing, Control of Breathing, Respiratory Muscles, Pulmonary Function Testing, Nitric Oxide, and Bronchoscopy in AJRCCM 2000
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1362 - 1375.
[Full Text] [PDF]

Home page
 JAMAHome page
J. M. Luce and J. A. Luce
Management of Dyspnea in Patients With Far-Advanced Lung Disease: "Once I Lose It, It's Kind of Hard to Catch It . . . "
JAMA, March 14, 2001; 285(10): 1331 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. SUDO, F. HAYASHI, and T. NISHINO
Responses of Tracheobronchial Receptors to Inhaled Furosemide in Anesthetized Rats
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 971 - 975.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society 		  2009 ATS Conference Fees